Schizophrenia Research Review Issue 45
In this issue:
Phenotypic severity & medication/pharmacogenomic variables in schizophrenia
Different pharmacotherapies in treatment-resistant schizophrenia
Moral decision-making in schizophrenia
CBT for negative symptoms & function in schizophrenia
COaST: semaglutide in patients with schizophrenia & obesity on clozapine
STARLYNG: long-acting oral weekly risperidone (LYN-005) in schizophrenia
EEG features with refractory positive symptoms in schizophrenia
Cardiovascular disease/risk factors in schizophrenia
Predictors of remission in real-world patients receiving once-monthly aripiprazole
Cumulative incidence of schizophrenia in an Australia centre
Expert contributor
Professor Dan Siskind
Professor Siskind trained as a psychiatrist in Australia and the United States. He works clinically as a psychiatrist in Brisbane, Australia with people with treatment-refractory schizophrenia. His research interests include treatment-refractory schizophrenia, clozapine and the physical health comorbidities associated with schizophrenia. He has over 300 publications and AU$60million in competitive research grants, with over AU$7 […]
Latest Publications and Videos
Stay up to date with our latest clinical information.
Explore Research Review Publications and Videos
Dive into our publications and videos content from over 50 areas of medicine including Cardiology, Diabetes, Oncology, Haematology and Psychiatry.
Terms and Conditions
Website terms of use
By using our website, you agree to follow these terms and conditions.
Privacy policy
We take your privacy seriously. To understand how we collect, use, and protect your information, please read our Privacy Policy, which is part of these terms.
Copyright and use of website content
The content of our website is protected by copyright, trademarks, and other legal rights. You can: view, download, or print a single copy of content for your personal or professional use.
You cannot: copy, modify, or distribute website content, or use our website content for commercial purposes or in other works without permission.
Links to third-party websites
The Research Review website may link to third-party websites for your convenience. However:
We do not endorse or approve their products, services, or actions.
We are not responsible for their content or how they operate.
There is no formal partnership between us and third parties unless we clearly state otherwise.
Disclaimer and limitation of liability
We do our best to keep the information on our website accurate, but we do not guarantee that it is always correct or up to date.
To the fullest extent allowed by law, we are not responsible for:
Any loss, damage, or costs you may suffer from using (or being unable to use) our website.
Any decisions you make based on the information provided.
Any business losses, such as lost profits, lost data, or business interruptions.
Governing law
These terms are governed by New Zealand law. If there is a dispute, it must be resolved in a New Zealand court.